Pharma Pulse 7/2/24: AI’s Promise in Delivering on Patient-Centricity, What’s Complicating Good Data Practices and Data Integrity? & more

AI’s Promise in Delivering on Patient-Centricity

How pharmaceutical companies can utilize AI at key stages of the treatment journey to enhance patient-centric engagement by increasing empathy and humanity in patient interactions.

What’s Complicating Good Data Practices and Data Integrity?

As the data management landscape continues to shift and change with AI and technological advancements all around us, it is essential to maintain good data practices and ensure data integrity in pharmaceutical research and development.

Amazon, Built by Retail, Invests in Its AI Future

The freshly minted $2 trillion company is now investing more on data-center infrastructure than on retail warehouses.

Radionetics Oncology Enters Into Strategic Agreement With Lilly
Radionetics Oncology, a biotechnology company discovering and developing novel small molecule G protein coupled receptor (GPCR) targeted radiopharmaceuticals to treat a broad range of solid tumors, announced today the formation of a strategic relationship with Eli Lilly and Company to take forward Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals.

Blake Powers on LinkedIn

I was invited to write an op-ed for Pharmaceutical Commerce Magazine and it published earlier this month: https://lnkd.in/esmVX3gF
In the piece, I explore how the drug supply chain might benefit (as other sectors have) from dynamic pricing models and digital applications.

Have news you want us to share in Pharma Pulse? Reach out to Social

Media Editor Miranda Schmalfuhs